Offerman EH[au] - Search Results

Year	Number of Results
2001	1
2002	1
2004	2
2005	2
2006	1
2007	2
2013	1
2014	1
2024	0

1

APOE*3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome.

van den Hoek AM, van der Hoorn JW, Maas AC, van den Hoogen RM, van Nieuwkoop A, Droog S, Offerman EH, Pieterman EJ, Havekes LM, Princen HM. van den Hoek AM, et al. Among authors: offerman eh. Diabetes Obes Metab. 2014 Jun;16(6):537-44. doi: 10.1111/dom.12252. Epub 2014 Jan 16. Diabetes Obes Metab. 2014. PMID: 24373179

2

Apolipoprotein C-I binds free fatty acids and reduces their intracellular esterification.

Westerterp M, Berbée JF, Delsing DJ, Jong MC, Gijbels MJ, Dahlmans VE, Offerman EH, Romijn JA, Havekes LM, Rensen PC. Westerterp M, et al. Among authors: offerman eh. J Lipid Res. 2007 Jun;48(6):1353-61. doi: 10.1194/jlr.M700024-JLR200. Epub 2007 Mar 5. J Lipid Res. 2007. PMID: 17339654 Free article.

3

Absence of an atheroprotective effect of the garlic powder printanor in APOE*3-Leiden transgenic mice.

Espirito Santo SM, van Vlijmen BJ, van Duyvenvoorde W, Offerman EH, Havekes LM, Arnault I, Auger J, Princen HM. Espirito Santo SM, et al. Among authors: offerman eh. Atherosclerosis. 2004 Dec;177(2):291-7. doi: 10.1016/j.atherosclerosis.2004.07.024. Atherosclerosis. 2004. PMID: 15530902

4

No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice.

Trion A, de Maat MP, Jukema JW, van der Laarse A, Maas MC, Offerman EH, Havekes LM, Szalai AJ, Princen HM, Emeis JJ. Trion A, et al. Among authors: offerman eh. Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1635-40. doi: 10.1161/01.ATV.0000171992.36710.1e. Epub 2005 May 26. Arterioscler Thromb Vasc Biol. 2005. PMID: 15920036

5

Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.

Westerterp M, van der Hoogt CC, de Haan W, Offerman EH, Dallinga-Thie GM, Jukema JW, Havekes LM, Rensen PC. Westerterp M, et al. Among authors: offerman eh. Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2552-9. doi: 10.1161/01.ATV.0000243925.65265.3c. Epub 2006 Aug 31. Arterioscler Thromb Vasc Biol. 2006. PMID: 16946130 Free article.

6

Apolipoprotein CI aggravates atherosclerosis development in ApoE-knockout mice despite mediating cholesterol efflux from macrophages.

Westerterp M, Van Eck M, de Haan W, Offerman EH, Van Berkel TJ, Havekes LM, Rensen PC. Westerterp M, et al. Among authors: offerman eh. Atherosclerosis. 2007 Nov;195(1):e9-16. doi: 10.1016/j.atherosclerosis.2007.01.015. Epub 2007 Feb 23. Atherosclerosis. 2007. PMID: 17320883

7

Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice.

Delsing DJ, Offerman EH, van Duyvenvoorde W, van Der Boom H, de Wit EC, Gijbels MJ, van Der Laarse A, Jukema JW, Havekes LM, Princen HM. Delsing DJ, et al. Among authors: offerman eh. Circulation. 2001 Apr 3;103(13):1778-86. doi: 10.1161/01.cir.103.13.1778. Circulation. 2001. PMID: 11282910

8

Combined analysis of pharmacokinetic and efficacy data of preclinical studies with statins markedly improves translation of drug efficacy to human trials.

van de Steeg E, Kleemann R, Jansen HT, van Duyvenvoorde W, Offerman EH, Wortelboer HM, Degroot J. van de Steeg E, et al. Among authors: offerman eh. J Pharmacol Exp Ther. 2013 Dec;347(3):635-44. doi: 10.1124/jpet.113.208595. Epub 2013 Sep 18. J Pharmacol Exp Ther. 2013. PMID: 24049060

9

Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.

Verschuren L, Kleemann R, Offerman EH, Szalai AJ, Emeis SJ, Princen HM, Kooistra T. Verschuren L, et al. Among authors: offerman eh. Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):161-7. doi: 10.1161/01.ATV.0000148866.29829.19. Epub 2004 Oct 28. Arterioscler Thromb Vasc Biol. 2005. PMID: 15514207

10

Overexpression of fibrinogen in ApoE*3-Leiden transgenic mice does not influence the progression of diet-induced atherosclerosis.

Rezaee F, Gijbels MJ, Offerman EH, van der Linden M, De Maat MP, Verheijen JH. Rezaee F, et al. Among authors: offerman eh. Thromb Haemost. 2002 Aug;88(2):329-34. Thromb Haemost. 2002. PMID: 12195708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year